Schroeder Amy, Jimenez Robyn, Young Briana, Privalsky Martin L
Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California at Davis, Davis, California 95616.
Mol Endocrinol. 2014 May;28(5):745-57. doi: 10.1210/me.2013-1335. Epub 2014 Mar 27.
T4 (3,5,3',5'-tetraiodo-l-thyronine) is classically viewed as a prohormone that must be converted to the T3 (3,5,3'-triiodo-l-thyronine) form for biological activity. We first determined that the ability of reporter genes to respond to T4 and to T3 differed for the different thyroid hormone receptor (TR) isoforms, with TRα1 generally more responsive to T4 than was TRβ1. The response to T4 vs T3 also differed dramatically in different cell types in a manner that could not be attributed to differences in deiodinase activity or in hormone affinity, leading us to examine the role of TR coregulators in this phenomenon. Unexpectedly, several coactivators, such as steroid receptor coactivator-1 (SRC1) and thyroid hormone receptor-associated protein 220 (TRAP220), were recruited to TRα1 nearly equally by T4 as by T3 in vitro, indicating that TRα1 possesses an innate potential to respond efficiently to T4 as an agonist. In contrast, release of corepressors, such as the nuclear receptor coreceptor NCoRω, from TRα1 by T4 was relatively inefficient, requiring considerably higher concentrations of this ligand than did coactivator recruitment. Our results suggest that cells, by altering the repertoire and abundance of corepressors and coactivators expressed, may regulate their ability to respond to T4, raising the possibility that T4 may function directly as a hormone in specific cellular or physiological contexts.
传统观点认为,T4(3,5,3',5'-四碘-L-甲状腺原氨酸)是一种前体激素,必须转化为T3(3,5,3'-三碘-L-甲状腺原氨酸)形式才具有生物活性。我们首先确定,不同的甲状腺激素受体(TR)亚型中,报告基因对T4和T3的反应能力存在差异,TRα1通常比TRβ1对T4的反应更灵敏。在不同细胞类型中,T4与T3的反应也存在显著差异,这种差异无法归因于脱碘酶活性或激素亲和力的不同,这促使我们研究TR共调节因子在这一现象中的作用。出乎意料的是,在体外,T4和T3几乎能同等程度地将几种共激活因子,如类固醇受体共激活因子-1(SRC1)和甲状腺激素受体相关蛋白220(TRAP220)募集到TRα1上,这表明TRα1具有作为激动剂有效响应T4的内在潜力。相比之下,T4促使TRα1释放共抑制因子,如核受体共抑制因子NCoRω的效率相对较低,所需的该配体浓度比募集共激活因子时要高得多。我们的研究结果表明,细胞可能通过改变所表达的共抑制因子和共激活因子的种类及丰度来调节其对T4的反应能力,这增加了T4在特定细胞或生理环境中可能直接作为激素发挥作用的可能性。